The Future of Medicine: Testing Hot-From-The-Lab Cancer-Killing Drugs
Olivier Rixe, Hematologist/Oncologist, Early Stage Drug Development Program and Phase I Unit at the University of Cincinnati Cancer Institute
The university asked me to develop this Phase I program, the first [step] in human clinical trials, as part of UC’s cancer institute. There are few Phase I centers in the United States, maybe 10 to 15. We have new drugs, new strategies [researchers] want to investigate, and I am here to run the trials and to translate this knowledge from bench to bedside.